SCHEMBL5089072

SCHEMBL5089072

Cc1cc(N(CC(=O)O)C(=O)Cc2cc(C(=N)NO)ccc2OCc2ccccc2)ccc1C(=O)N1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.38
HPGD P15428 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MAPT P10636 2/20 0.38
ALDH1A1 P00352 1/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
HDAC1 Q13547 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
SMPD1 P17405 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
APP P05067 3/20 0.35
SCN9A Q15858 1/20 0.35
AR P10275 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5091451 0.89 HPGD (0.39) HSD17B10HPGDMAPTALDH1A1LMNA
SCHEMBL5093093 0.85 HPGD (0.38) HPGDALDH1A1LMNAHDAC1HDAC6
SCHEMBL7370559 0.82 MET (0.41) HSD17B10HPGDNPC1RAB9AMAPT
SCHEMBL5094320 0.81 HSD17B10 (0.41) HSD17B10HPGDNPC1RAB9AMAPT
SCHEMBL6554470 0.80 SMPD1 (0.43) HSD17B10HPGDNPC1RAB9AMAPT
SCHEMBL5094291 0.80 HSD17B10 (0.40) HSD17B10HPGDNPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL5098989 0.80 HSD17B10 (0.40) HSD17B10HPGDNPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL5099777 0.80 HSD17B10 (0.40) HSD17B10HPGDNPC1RAB9AMAPT
SCHEMBL5094325 0.74 SLC6A9 (0.41) HSD17B10NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL5094227 0.74 MET (0.41) HSD17B10HPGDNPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425641-B2 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA KG (DE) 2008-09-16 US disclosed
US-20050065346-A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-03-24 US disclosed
EP-1206446-B1 CARBOXYLIC ACID AMIDES, THEIR PRODUCTION AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA (DE) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065346-A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions F12, F11, F2 HSD17B10 1622/4885HPGD 870/4885NPC1 2081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.